CLINICAL_TRIALS
trial_result
· 2024-06-28
Clinical Trial Update: 68Ga PSMA PET for Patients With Biochemical Recurrence of Prostate Cancer [Phase 2, Phase 3]
Summary
Clinical trial update on 68Ga-PSMA PET imaging for biochemical recurrence of prostate cancer, with Phase 2/3 results posted in 2024.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Michael Graham PhD, MD | Conditions: Prostate Cancer, Prostatic Neoplasm | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2024-06-28